NCT02639117View on ClinicalTrials.gov

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

PHASE1CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 2, 2016

Study Completion Date

November 18, 2017

Conditions

Basal Cell Carcinoma

Interventions

DRUG

Vismodegib

Vismodegib 150 mgs po qd for 3 months

Trial Locations (1)

85719

Arizona Cancer Center, Tucson

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Arizona

OTHER